Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Amodiachin
2. Amodiaquin
3. Amodiaquine
4. Camoquin
5. Camoquine
6. Flavoquine
7. Hydrochloride, Amodiaquine
1. 69-44-3
2. Acrichin Dihydrochloride
3. Amodiaquin Dihydrochloride
4. Amodiaquine Hydrochloride Anhydrous
5. 4-((7-chloroquinolin-4-yl)amino)-2-((diethylamino)methyl)phenol Dihydrochloride
6. Amodiaquine (dihydrochloride)
7. Hoe64181mp
8. Camoquin Hydrochloride
9. Phenol, 4-((7-chloro-4-quinolinyl)amino)-2-((diethylamino)methyl)-, Dihydrochloride
10. 7-chloro-4-(3'-diethylaminomethyl-4'-hydroxyanilino)quinoline Dihydrochloride
11. 4-[(7-chloroquinolin-4-yl)amino]-2-[(diethylamino)methyl]phenol Dihydrochloride
12. 4-((7-chloroquinolin-4-yl)amino)-2-((diethylamino)-methyl)phenol 2hcl
13. 4-((7-chloroquinolin-4-yl)amino)-2-((diethylamino)-methyl)phenol Dihydrochloride
14. Einecs 200-706-0
15. Unii-hoe64181mp
16. Ai3-52838
17. Acrichindihydrochloride
18. 4-((7-chloro-4-quinolyl)amino)-alpha-(diethylamino)-o-cresol Dihydrochloride
19. 4-(7-chloro-4-quinolylamino)-alpha-(diethylamino)-o-cresol Dihydrochloride
20. Schembl317888
21. Amodiaquinedihydrochloride
22. Chembl3137745
23. Hy-b1322b
24. Dtxsid20219036
25. Kuc110919c
26. Bcp34401
27. Mfcd00078857
28. S5500
29. 4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol Dihydrochloride
30. 4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;dihydrochloride
31. Akos015962122
32. Ccg-268988
33. Ds-4067
34. Sb73131
35. Ksc-280-058
36. O-cresol, 4-((7-chloro-4-quinolyl)amino)-alpha-(diethylamino)-, Dihydrochloride
37. 2-[[bis(1,1,2,2,2-pentadeuterioethyl)amino]methyl]-4-[(7-chloroquinolin-4-yl)amino]phenol;dihydrochl
38. Ac-15935
39. Amodiaquine 2hcl;acrichin Dihydrochloride
40. Amodiaquine Dihydrochloride Anhydrous
41. Amodiaquine Dihydrochloride, Anhydrous
42. Cs-0013341
43. Ft-0650478
44. F16487
45. W-104623
46. Q27280034
47. 4-((7-chloro-4-quinolyl)amino)-.alpha.-(diethylamino)-o-cresol Dihydrochloride
48. 4-(7-chloroquinolin-4-ylamino)-2-((diethylamino)methyl)phenol Dihydrochloride
49. 4-[(7-chloro-4-quinolinyl)amino]-2-[(diethylamino)methyl]phenol Dihydrochloride
50. 2-[[bis(1,1,2,2,2-pentadeuterioethyl)amino]methyl]-4-[(7-chloroquinolin-4-yl)amino]phenol;dihydrochloride
51. O-cresol, 4-((7-chloro-4-quinolyl)amino)-.alpha.-(diethylamino)-, Dihydrochloride Anhydrous
| Molecular Weight | 428.8 g/mol |
|---|---|
| Molecular Formula | C20H24Cl3N3O |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 427.098495 g/mol |
| Monoisotopic Mass | 427.098495 g/mol |
| Topological Polar Surface Area | 48.4 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 406 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
Market Place
ABOUT THIS PAGE
19
PharmaCompass offers a list of Amodiaquine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Amodiaquine Hydrochloride manufacturer or Amodiaquine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amodiaquine Hydrochloride manufacturer or Amodiaquine Hydrochloride supplier.
A Camoquine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Camoquine, including repackagers and relabelers. The FDA regulates Camoquine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Camoquine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Camoquine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Camoquine supplier is an individual or a company that provides Camoquine active pharmaceutical ingredient (API) or Camoquine finished formulations upon request. The Camoquine suppliers may include Camoquine API manufacturers, exporters, distributors and traders.
click here to find a list of Camoquine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Camoquine DMF (Drug Master File) is a document detailing the whole manufacturing process of Camoquine active pharmaceutical ingredient (API) in detail. Different forms of Camoquine DMFs exist exist since differing nations have different regulations, such as Camoquine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Camoquine DMF submitted to regulatory agencies in the US is known as a USDMF. Camoquine USDMF includes data on Camoquine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Camoquine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Camoquine suppliers with USDMF on PharmaCompass.
A Camoquine written confirmation (Camoquine WC) is an official document issued by a regulatory agency to a Camoquine manufacturer, verifying that the manufacturing facility of a Camoquine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Camoquine APIs or Camoquine finished pharmaceutical products to another nation, regulatory agencies frequently require a Camoquine WC (written confirmation) as part of the regulatory process.
click here to find a list of Camoquine suppliers with Written Confirmation (WC) on PharmaCompass.
Camoquine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Camoquine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Camoquine GMP manufacturer or Camoquine GMP API supplier for your needs.
A Camoquine CoA (Certificate of Analysis) is a formal document that attests to Camoquine's compliance with Camoquine specifications and serves as a tool for batch-level quality control.
Camoquine CoA mostly includes findings from lab analyses of a specific batch. For each Camoquine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Camoquine may be tested according to a variety of international standards, such as European Pharmacopoeia (Camoquine EP), Camoquine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Camoquine USP).